Skip to main content Skip to menu Skip to footer
Home
  • Contact Us
  • Join us
  • Make an appointment
  • Donors
    • Patients and relatives
    • Researchers
    • Students
    • Caregivers
    • Journalists
    • TechTransfer
Search
Directory of Doctors
  • FR
  • EN
Make a donation
  • Who we are
    • Our history
    • Annual Report
    • International relations
    • Our economic model
    • Our missions
    • Our organization
  • Understand cancer
    • Breast cancer
    • Childhood cancers
    • Immunotherapy
    • Retinoblastoma
    • Sarcomas
    • Uveal melanoma
    • Proton therapy
    • Developing the Radiotherapy of the Future
    • Lung cancer
  • Support us
    • Where do your donations go?
    • Get involved
    • Our supporters
    • Where does your donation go?
  • Strategic priorities
    • Breast cancer
    • Early trials
    • Genetics and epigenetics
    • Immunotherapy
    • Pediatric cancer
    • Radiotherapy and radiation biology
    • Sarcomas
    • Uveal melanoma
  • Annual report
  • News
Breadcrumb
  1. Institut Curie
  2. Donors
  3. Our clinical trials

Our clinical trials

Filter by

  • ouverts (-)
  • fermés (-)
  • Saint-Cloud (-)
  • Recherches "plusieurs pathologies" (-)
  • Sein métastatique RH+ (-)
  • Sein Néoadjuvant (-)
  • Appareil pulmonaire (-)
  • Sein Métastatique (-)
  • Hématologie Leucémie (-)
  • Sein métastatique HER2+ (-)
  • VADS (-)
  • Phase II (-)
  • Etude clinique (-)

Localisation géographique

  • Paris (70)
  • Saint-Cloud (29) (-)

Age

  • Adulte (29)

Organe

  • Recherches "plusieurs pathologies" (10) (-)
  • Appareil Digestif (7)
  • Sein métastatique RH+ (7) (-)
  • Sein Néoadjuvant (5) (-)
  • Sein Adjuvant (3)
  • Anesthésie - Douleur (CLUD) (2)
  • Appareil pulmonaire (2) (-)
  • Hématologie Lymphome non Hodgkinien (2)
  • Sein (2)
  • Sein Métastatique (2) (-)
  • Sein métastatique triple négatif (2)
  • Gynécologie (1)
  • Gynécologie - Ovaires (1)
  • Hématologie Leucémie (1) (-)
  • Hématologie Myélodysplasie (1)
  • Sein métastatique HER2+ (1) (-)
  • Soins de support (1)
  • VADS (1) (-)

Phase

  • Phase III (26)
  • Phase II (15) (-)
  • Etude clinique (14) (-)
  • Phase IV (3)
  • Phase I/II (2)
  • Phase II/III (2)
  • Phase I (1)

Essai

  • ouverts (20) (-)
  • fermés (9) (-)
Appareil pulmonaire
PACT-01
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
Paris, Saint-Cloud
CATHERINE DANIEL, MARIE ANGE MASSIANI
Sein Métastatique
SAFIR02 Breast
Evaluation of the Efficacy of High Throughput Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer.
Paris, Saint-Cloud
MARIE PAULE SABLIN
Sein métastatique RH+
SAFIR PI3K
A Phase II Randomized Trial Comparing Alpelisib and Fulvestrant Versus Chemotherapy as Maintenance Therapy in Patients With PIK3CA Mutated Advanced Breast Cancer
Paris, Saint-Cloud
Sein métastatique RH+
SAFIR-TOR
Identification of the Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor of HR+ Metastatic Breast Cancer in Post-menopausal Women.
Paris, Saint-Cloud
PAUL-HENRI COTTU
Recherches "plusieurs pathologies"
SHIVA02 (IC 2016-06)
Evaluation of the Efficacy of Targeted Therapy Based on Tumor Molecular Profiling in Patients With Advanced Cancer Using Each Patient as Its Own Control.
Paris, Saint-Cloud
CHRISTOPHE LE TOURNEAU
Sein Néoadjuvant
ULTIMATE
A Phase II Trial Testing Durvalumab Combined With Endocrine Therapy in Patients With ER+/Her2- Breast Cancer Eligible for Neoadjuvant Endocrine Therapy And Who Present CD8+ T Cell Infiltration After 4-6 Weeks Exposure to Immune-Attractant
Paris, Saint-Cloud
PAUL-HENRI COTTU, ETIENNE BRAIN
Sein Néoadjuvant
ALIENOR
Detection of Circulating Tumoral DNA Mutations (Sequential Assessment) Following Neoadjuvant Chemotherapy for Breast Cancer: Clinical Validity (ALIENOR Study)
Paris, Saint-Cloud
Sein métastatique RH+
HerSeq (PUMA-NER-9501)
HER-Seq: A Blood-based Screening Study to Identify Patients with HER2 Mutations for;Enrollment into Clinical Research Studies of Neratinib
Paris, Saint-Cloud
Sein métastatique RH+
PALATINE - UC-0140/1814
ADVANCED BREAST CANCER: THERAPY INTEGRATING LOCOREGIONAL TREATMENT IN DE NOVO,;TREATMENT NAIVE, STAGE IV ER+, HER2- BREAST CANCER PATIENTS RECEIVING LETROZOLE AND;PALBOCICLIB
Paris, Saint-Cloud
VADS
MIBI-THYR
Value of the Combination Ultrasonography With Ti-RADS Score / Dual Tracer Scintigraphy MIBI-Tc99m/Iodine-123 in the Detection of Malignancy of Thyroid Nodules (Sup or Egal to 15 mm) Classified Bethesda III or IV on Cytology.
Saint-Cloud

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page suivante Next page ›
  • Last page Last »
Sign up to our Newsletter
Join us
Follow us
  • facebook
  • twitter
  • linkedin
  • instagram
Patients and relatives
  • Our hospitals
  • Adult care
  • International patients
  • What is a clinical trial?
  • Care News
Access this area
Donors
  • Who we are
  • Understand cancer
  • Support us
  • Strategic priorities
  • Annual report
  • News
Access this area
Researchers
  • Research Center
  • Research Themes
  • Research Units
  • Research Teams
  • Core Facilities
  • Seminars
  • Programs and partnerships
  • Training
  • Join us
  • Research News
Access this area
Students
  • Courses
  • The hospital
  • The Research Center
  • Collaborations
  • ADIC
  • Training News
Access this area
Caregivers
  • Refer a patient
  • Understanding cancer
  • Our expertise
  • Our hospitals
  • Contact Us
  • Care News
Access this area
Journalists
Access this area
TechTransfer
  • About us
Access this area
  • Copyright © 2023
  • Contact and Access
  • Contact Us
  • Directory
  • Join us
  • Legal Notice
  • Personal data protection charter